News & Activities
As a young company, Amferia is growing fast and establishing ground both in Sweden and Internationally. To keep updated on our progress and activities, do check on the below posts and don’t hesitate to contact us if you would like to know more.
News & Activities
Amferia is proud to be selected as “One-to-Watch” company of 2020 by the Nature Research and Merck KGaA, as part of the Nature Research Spin-Off Awards!
This is a wonderful recognition of the top 44 university spin-off’s from around the world! A big thanks to Chalmers University of Technology & Chalmers Ventures for the continued support for Amferia and our growth! 🙂
More to read here: https://lnkd.in/dZtwz4t
Saba had the pleasure of speaking at the Women in Tech 2020
06 March 2020
Watch the entire talk on our homepage
Amferia’s CTO, Saba Atefyekta is a PhD in Materials Science .
07 February 2020
Yesterday, Saba successfully defended her thesis (and work of true importance), ‘Antibacterial Surfaces for Biomedical Applications’ with a highly engaging discussion with her opponent and pioneer in the field, Professor Henk Busscher from the Netherlands.
Congratulations Doctor Atefyekta!
Amferia is happy to announce its raising of SEK 6.2 million in investment .
Almi Invest, Chalmers Ventures, along with the British investor Corithinan Properties Ltd. and Let’s Deal Founder Alexander Hars have invested a total of SEK 6.2 million in Amferia, for commercialising our wound care product that actively combats infections and kills antibiotic-resistant bacteria. Read press release here:Investment Press release_Amferia
Amferia’s Founders publish results in high impact nanotechnology journal, ACS Nano.
20 December 2019
Introducing a new class of elastomer materials! Want to know more? Check out this interesting article published in the prestigious journal ACS Nano, by our Founders Anand, Martin and colleagues from Chalmers University of Technology. https://pubs.acs.org/doi/abs/10.1021/acsnano.9b01924
Amferia at 2nd Soirée Franco-Suédoise, Paris
December 2, 2019
We had the honour to be part of the 2nd Soirée Franco-Suédoise at Palais d’Iéna organized by Chambre de Commerce Suédoise en France – CCSF and represent Amferia as one of the innovative med-tech start-up from Sweden. Big thanks to Katarina Lööf and the Chambre de Commerce Suédoise en France – CCSF for inviting Amferia and introducing us to new possibilities in France. hashtag#innovation hashtag#antibioticresistance
Photo copyright Swedish Chamber of Commerce in France and photographer Kristofer Sandberg.
Invited to Pitch for L’Oréal Paris as part of the European Innovation Council
November 26, 2019
Amferia had the honor to present our work at L’Oréal, Paris as part of the European Innovation Council’s corporate days. A lot of inspiring discussions and 1-1’s on synergies within the cosmetic research. Big thanks to the EU Commission, EUeic and L’Oréal for organising and hosting us. Also a big thank you to Chalmers Ventures for offering valuable support for Amferia to attend the event.
Amferia establishes R&D operations at AstraZeneca’s BioVentureHub
October 28, 2019
Amferia is very excited to move into the BioVentureHub, given the strong benefits of operating in a flourishing environment with state-of-the-art infrastructure dedicated to medtech and life science companies. We are also eager to be around so many experts within life science ranging from established to early-stage companies researching in biopharmaceuticals, medical devices and diagnostics. Amferia looks forward to be part of, learn and grow in this supportive and exciting community. Read press release here: Amferia AZ Press Release
Amferia Participates in the Annual Veterinary Hygiene Conference 2019
October 24, 2019
Our CEO, Anand Kumar Rajasekharan and Product Engineer, Edvin Blomstrand had the pleasure to recently attend the annual Veterinary Hygiene Conference in Knivsta, Stockholm. One of the primary questions of this conference was about handling antibiotic resistant infections in animal wound care – a fast growing problem in Sweden and Globally. Many interesting & enlightening discussions with expert veterinary clinicians taught us a lot about the needs and challenges in animal wound care and how Amferia might expand its innovative solutions to help veterinary healthcare. Thanks for a great conference VVHF.
Amferia receives the prestigious EU SME Instrument (Phase 1) Grant from the European Union
Aug 1, 2019
Amferia recieves the highly competitive and coveted EU SME Instrument Phase 1 grant of 50k Euros along with the valuable business coaching to take forward our technology into the market.
Amferia at Brilliant Minds 2019, Stockholm
June 15, 2019
Amferia was honored to pitch as one of the ‘Next Brilliant in Tech‘ at Brilliant Minds 2019 held at Stockholm between 13-15 June. With esteemed guests like President Barack Obama, Secretary John Kerry, Greta Thunberg, the conference was a enlighetening and inspiring event with much hope for the future.
Our CEO, Anand conferred a PhD in Materials Science
May 18, 2019.
Chalmers Doktorspromotion 2019
Anand was also invited to speak at the ceremony about how a research study opened pathways to entrepreneurship and to the birth of Amferia. Thank you Chalmers for the wonderful oppurtunity!
Amferia is ‘Student Superstart’!
– Venture Cup Väst 2019
May 21, 2019
Once again Amferiashows up among the winners! We are so proud to be one of the winners of region west Venture Cup 2019. Such a fantastic event filled with inspiration and excitement.
The Recent UN Report on Antibiotic Resistance
May 3, 2019
The United Nations appointed Interagency Coordination Group on Antimicrobial Resistance (IACG) has presented its report on Recommendations to Combat Antimicrobial Resistance (AMR). It is clear from the report that AMR is a global and complex threat that needs to be addressed with extreme urgency and with care. Consistent, coordinated and conscious actions are demanded, especially from the World Goverments, Academia, Public, Healthcare-Industry and Agriculture. A world where bacterial infections cannot be fought efficiently is a world of perils.
Here is an excerpt from the IACG report.
“The challenges of antimicrobial resistance are complex and multifaceted, but they are not insurmountable. Implementation of the recommendations in this report will help to save millions of lives, preserve antimicrobials for generations to come and secure the future from drug-resistant diseases.
But there is no time to wait.”
-IACG Report, April 29, 2019
Do take a minute and read the summary of this important report Englishpdf, 653kb
Amferia presenting at the European Wound Management Conference (EWMA) 2019
In June, Anand will give a presentation about Amferia’s technology at the EWMA conference this year. Please let us know if you would like to meet and discuss more at the congress. Anand’s talk is on 5th June within the Antimicrobial session.
PODCAST
Amferia on Låt Oss Prata – Juan Navas, Swedbank May 3, 2019
Our CEO, Anand had a chat with Juan Navas from Swedbank on Swedbank’s official podcast, Låt Oss Prata (Let’s Talk). Anand and Juan discuss Amferia’s recent experience on winning the Swedbank Rivstart Entrepreneur competition.
Amferia featured in Göteborgs-Posten
February 8, 2019
Read on to know more
Amferia wins the Swedbank Rivstart 2018
February 7, 2019
Amferia is proud to become the winners of the annual entrepreneur competition hosted by Swedbank, Rivstart. From over 1825 applications, Amferia finished on top!
